Literature DB >> 24258322

An examination of the NAACCR method of assessing completeness of case ascertainment using the Canadian Cancer Registry.

Dianne Zakaria1.   

Abstract

BACKGROUND: Despite use of the North American Association of Central Cancer Registries' indicator for assessing completeness of case ascertainment in population-based cancer registries, little has been published about its methodology, usefulness and accuracy in Canada. DATA AND METHODS: Canadian cancer incidence, cancer mortality, and population census data were used to quantify case completeness in 2007. Two indicators (I₁ and I₂) that expressed the observed age-standardized incidence rate relative to the expected rate were calculated. The assumption of stable age-standardized sex- and cancer-site-specific incidence-to-mortality rate ratios across regions was assessed. Associations between I₁, I₂ and simpler indicators of completeness were examined.
RESULTS: The assumption of stable age-standardized sex- and cancer-site-specific incidence-to-mortality rate ratios across regions was not consistently supported—substantial regional differences emerged. I₁ was strongly correlated with I₂ (r=0.93, n=315, p<0.0001), and both were most strongly and consistently associated with the age-standardized incidence-to-mortality rate ratio. The frequency of undercoverage did not increase consistently with expected case-finding difficulty.
INTERPRETATION: The age-standardized incidence-to-mortality rate ratio may provide a less complicated method of identifying undercoverage.

Entities:  

Keywords:  SEER Program; cancer; data collection; incidence; mortality; neoplasms; registries

Mesh:

Year:  2013        PMID: 24258322

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  2 in total

1.  Low radon exposures and lung cancer risk: joint analysis of the Czech, French, and Beaverlodge cohorts of uranium miners.

Authors:  Rachel S D Lane; Ladislav Tomášek; Lydia B Zablotska; Estelle Rage; Franco Momoli; Julian Little
Journal:  Int Arch Occup Environ Health       Date:  2019-02-08       Impact factor: 3.015

2.  Brain Metastases among Cancer Patients Diagnosed from 2010-2017 in Canada: Incidence Proportion at Diagnosis and Estimated Lifetime Incidence.

Authors:  Jiaqi L Liu; Emily V Walker; Yuba Raj Paudel; Faith G Davis; Yan Yuan
Journal:  Curr Oncol       Date:  2022-03-18       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.